

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sperm motility (GO:0030317) | 5.61595474 |
| 2 | acrosome reaction (GO:0007340) | 5.05208916 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.83758029 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.83758029 |
| 5 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.70985754 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.56994649 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.56994649 |
| 8 | sperm-egg recognition (GO:0035036) | 4.41217102 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.33588453 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.22982039 |
| 11 | binding of sperm to zona pellucida (GO:0007339) | 4.18200337 |
| 12 | acrosome assembly (GO:0001675) | 4.12050533 |
| 13 | coenzyme catabolic process (GO:0009109) | 4.08761904 |
| 14 | cofactor catabolic process (GO:0051187) | 3.97112263 |
| 15 | tryptophan catabolic process (GO:0006569) | 3.89696463 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 3.89696463 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 3.89696463 |
| 18 | cell-cell recognition (GO:0009988) | 3.84824414 |
| 19 | protein localization to endosome (GO:0036010) | 3.83018781 |
| 20 | spermatid development (GO:0007286) | 3.75847263 |
| 21 | tryptophan metabolic process (GO:0006568) | 3.75283811 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.75209303 |
| 23 | oxaloacetate metabolic process (GO:0006107) | 3.74091889 |
| 24 | urea cycle (GO:0000050) | 3.70511321 |
| 25 | urea metabolic process (GO:0019627) | 3.70511321 |
| 26 | NADH metabolic process (GO:0006734) | 3.69318814 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.65813978 |
| 28 | cell wall macromolecule metabolic process (GO:0044036) | 3.65710605 |
| 29 | cell wall macromolecule catabolic process (GO:0016998) | 3.65710605 |
| 30 | regulation of early endosome to late endosome transport (GO:2000641) | 3.64158564 |
| 31 | cysteine metabolic process (GO:0006534) | 3.63440668 |
| 32 | multicellular organism reproduction (GO:0032504) | 3.62468523 |
| 33 | plasma membrane fusion (GO:0045026) | 3.61036120 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54047487 |
| 35 | regulation of cilium movement (GO:0003352) | 3.53146034 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 3.52033711 |
| 37 | barbed-end actin filament capping (GO:0051016) | 3.51696234 |
| 38 | epithelial cilium movement (GO:0003351) | 3.51228597 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.51045398 |
| 40 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.49242494 |
| 41 | creatine metabolic process (GO:0006600) | 3.47448150 |
| 42 | negative regulation of cell size (GO:0045792) | 3.40993141 |
| 43 | aldehyde catabolic process (GO:0046185) | 3.39150115 |
| 44 | axonemal dynein complex assembly (GO:0070286) | 3.38949908 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.37153638 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 3.37138156 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.36819739 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 3.36604959 |
| 49 | motile cilium assembly (GO:0044458) | 3.34920950 |
| 50 | lysine catabolic process (GO:0006554) | 3.34012838 |
| 51 | lysine metabolic process (GO:0006553) | 3.34012838 |
| 52 | protein retention in ER lumen (GO:0006621) | 3.32863553 |
| 53 | succinate metabolic process (GO:0006105) | 3.31744445 |
| 54 | organic cation transport (GO:0015695) | 3.31712184 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 3.29959254 |
| 56 | proline biosynthetic process (GO:0006561) | 3.29170489 |
| 57 | peroxisome fission (GO:0016559) | 3.26845904 |
| 58 | COPI coating of Golgi vesicle (GO:0048205) | 3.26336281 |
| 59 | Golgi transport vesicle coating (GO:0048200) | 3.26336281 |
| 60 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.22354432 |
| 61 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.22354432 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.19301701 |
| 63 | piRNA metabolic process (GO:0034587) | 3.19296754 |
| 64 | regulation of inclusion body assembly (GO:0090083) | 3.17762932 |
| 65 | fructose metabolic process (GO:0006000) | 3.17686700 |
| 66 | reproduction (GO:0000003) | 3.17525908 |
| 67 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.17172581 |
| 68 | alditol metabolic process (GO:0019400) | 3.16317344 |
| 69 | aspartate family amino acid catabolic process (GO:0009068) | 3.15757474 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.13815540 |
| 71 | apoptotic process involved in morphogenesis (GO:0060561) | 3.12299132 |
| 72 | urate metabolic process (GO:0046415) | 3.12016359 |
| 73 | cell-substrate adherens junction assembly (GO:0007045) | 3.08986406 |
| 74 | focal adhesion assembly (GO:0048041) | 3.08986406 |
| 75 | tricarboxylic acid cycle (GO:0006099) | 3.05931882 |
| 76 | S-adenosylmethionine metabolic process (GO:0046500) | 3.04575622 |
| 77 | regulation of protein activation cascade (GO:2000257) | 3.03978134 |
| 78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.03889508 |
| 79 | complement activation, alternative pathway (GO:0006957) | 3.02162976 |
| 80 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01602887 |
| 81 | glyoxylate metabolic process (GO:0046487) | 3.01592548 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 3.00283005 |
| 83 | protein-lipid complex remodeling (GO:0034368) | 3.00283005 |
| 84 | macromolecular complex remodeling (GO:0034367) | 3.00283005 |
| 85 | adherens junction assembly (GO:0034333) | 3.00134877 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99470674 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99470674 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 2.99072255 |
| 89 | bile acid biosynthetic process (GO:0006699) | 2.98636495 |
| 90 | phospholipid efflux (GO:0033700) | 2.98296698 |
| 91 | male meiosis (GO:0007140) | 2.97498359 |
| 92 | single fertilization (GO:0007338) | 2.97283627 |
| 93 | sperm capacitation (GO:0048240) | 2.96391844 |
| 94 | negative regulation of sterol transport (GO:0032372) | 2.92864707 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 2.92864707 |
| 96 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.87490083 |
| 97 | chaperone-mediated protein transport (GO:0072321) | 2.87399702 |
| 98 | stress fiber assembly (GO:0043149) | 2.87126120 |
| 99 | regulation of complement activation (GO:0030449) | 2.86709758 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 2.86054354 |
| 101 | cell-substrate junction assembly (GO:0007044) | 2.85406540 |
| 102 | hexose biosynthetic process (GO:0019319) | 2.84646836 |
| 103 | reverse cholesterol transport (GO:0043691) | 2.83400875 |
| 104 | glycerol ether metabolic process (GO:0006662) | 2.83398324 |
| 105 | arginine metabolic process (GO:0006525) | 2.83307334 |
| 106 | low-density lipoprotein particle remodeling (GO:0034374) | 2.80948860 |
| 107 | desmosome organization (GO:0002934) | 2.80906270 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 2.79672805 |
| 109 | negative regulation of inclusion body assembly (GO:0090084) | 2.79325631 |
| 110 | drug catabolic process (GO:0042737) | 2.79154774 |
| 111 | synaptonemal complex organization (GO:0070193) | 2.79153883 |
| 112 | ketone body metabolic process (GO:1902224) | 2.79023786 |
| 113 | tyrosine metabolic process (GO:0006570) | 2.78744758 |
| 114 | glycerol metabolic process (GO:0006071) | 2.78285691 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.77672681 |
| 116 | protein carboxylation (GO:0018214) | 2.77672681 |
| 117 | glutamate metabolic process (GO:0006536) | 2.75415180 |
| 118 | actin-myosin filament sliding (GO:0033275) | 2.73269592 |
| 119 | muscle filament sliding (GO:0030049) | 2.73269592 |
| 120 | serine family amino acid metabolic process (GO:0009069) | 2.72105305 |
| 121 | regulation of fibrinolysis (GO:0051917) | 2.72010449 |
| 122 | indolalkylamine metabolic process (GO:0006586) | 2.71563019 |
| 123 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.71400605 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.71195915 |
| 125 | regulation of triglyceride catabolic process (GO:0010896) | 2.69939639 |
| 126 | cellular modified amino acid catabolic process (GO:0042219) | 2.68788254 |
| 127 | mannose metabolic process (GO:0006013) | 2.68632944 |
| 128 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.68235061 |
| 129 | modulation by symbiont of host cellular process (GO:0044068) | 2.67056302 |
| 130 | negative regulation of necroptotic process (GO:0060546) | 2.66437555 |
| 131 | positive regulation of myotube differentiation (GO:0010831) | 2.64370221 |
| 132 | activation of MAPKKK activity (GO:0000185) | 2.63401100 |
| 133 | proline metabolic process (GO:0006560) | 2.62054357 |
| 134 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61402973 |
| 135 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59776995 |
| 136 | activation of Rac GTPase activity (GO:0032863) | 2.59524699 |
| 137 | pinocytosis (GO:0006907) | 2.57119396 |
| 138 | skeletal muscle contraction (GO:0003009) | 2.56097566 |
| 139 | hemidesmosome assembly (GO:0031581) | 2.55251064 |
| 140 | basement membrane organization (GO:0071711) | 2.53469723 |
| 141 | regulation of necrotic cell death (GO:0010939) | 2.52914431 |
| 142 | semaphorin-plexin signaling pathway (GO:0071526) | 2.51225253 |
| 143 | glycosphingolipid catabolic process (GO:0046479) | 2.50911766 |
| 144 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.47952741 |
| 145 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.46609456 |
| 146 | pentose-phosphate shunt (GO:0006098) | 2.46562094 |
| 147 | positive regulation of receptor recycling (GO:0001921) | 2.44274702 |
| 148 | modulation by virus of host process (GO:0019054) | 2.44068909 |
| 149 | gluconeogenesis (GO:0006094) | 2.43304963 |
| 150 | adenosine receptor signaling pathway (GO:0001973) | 2.43078638 |
| 151 | regulation of cholesterol homeostasis (GO:2000188) | 2.40522035 |
| 152 | epithelial cell-cell adhesion (GO:0090136) | 2.39890095 |
| 153 | glucose catabolic process (GO:0006007) | 2.39183788 |
| 154 | monosaccharide biosynthetic process (GO:0046364) | 2.35878540 |
| 155 | positive regulation of protein dephosphorylation (GO:0035307) | 2.33110562 |
| 156 | UV protection (GO:0009650) | 2.32920362 |
| 157 | cell volume homeostasis (GO:0006884) | 2.32328965 |
| 158 | amyloid precursor protein catabolic process (GO:0042987) | 2.32113902 |
| 159 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.31546764 |
| 160 | adhesion of symbiont to host (GO:0044406) | 2.30925644 |
| 161 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.30221585 |
| 162 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.29662844 |
| 163 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.28377098 |
| 164 | cellular response to virus (GO:0098586) | 2.28327603 |
| 165 | regulation of necroptotic process (GO:0060544) | 2.27114779 |
| 166 | regulation of pseudopodium assembly (GO:0031272) | 2.26266889 |
| 167 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.24990002 |
| 168 | glycolipid catabolic process (GO:0019377) | 2.24371291 |
| 169 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.24366033 |
| 170 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.24098423 |
| 171 | regulation of skeletal muscle contraction (GO:0014819) | 2.23977996 |
| 172 | amyloid precursor protein metabolic process (GO:0042982) | 2.23497528 |
| 173 | sarcomere organization (GO:0045214) | 2.22435554 |
| 174 | cardiac muscle contraction (GO:0060048) | 2.22147240 |
| 175 | adhesion of symbiont to host cell (GO:0044650) | 2.21472542 |
| 176 | virion attachment to host cell (GO:0019062) | 2.21472542 |
| 177 | atrioventricular valve morphogenesis (GO:0003181) | 2.20317968 |
| 178 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.19785470 |
| 179 | response to laminar fluid shear stress (GO:0034616) | 2.19363451 |
| 180 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.18260947 |
| 181 | protein targeting to plasma membrane (GO:0072661) | 2.17612859 |
| 182 | 4-hydroxyproline metabolic process (GO:0019471) | 2.17318551 |
| 183 | regulation of extracellular matrix disassembly (GO:0010715) | 2.17001112 |
| 184 | glucose 6-phosphate metabolic process (GO:0051156) | 2.16566446 |
| 185 | regulation of cholesterol metabolic process (GO:0090181) | 2.16011100 |
| 186 | negative regulation of viral release from host cell (GO:1902187) | 2.15751135 |
| 187 | modulation by virus of host morphology or physiology (GO:0019048) | 2.15458275 |
| 188 | tricarboxylic acid metabolic process (GO:0072350) | 2.14392034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.92510682 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 4.73126542 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.03480194 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.43406411 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.41336145 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.25508998 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.06048100 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.98475017 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.93625435 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92246974 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91962496 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.85883563 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83223150 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.64901069 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.63356896 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.50824616 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37363080 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.36656914 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.36046846 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29703217 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29453952 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.21986362 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.14066881 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.08515601 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08213942 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 2.07350243 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01826857 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01598354 |
| 29 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.99901190 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.99584995 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.97517777 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.97287694 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.97041219 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.91005396 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89639323 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89243723 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.88227324 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82463964 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81510251 |
| 40 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.73547202 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72878894 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.71255032 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.68931497 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.68712815 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67193173 |
| 46 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.65443638 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59318290 |
| 48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58998373 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54863838 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53827781 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52650669 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52324672 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50799417 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50704817 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.50555899 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49695074 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.48684246 |
| 58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46272413 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45501656 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44889327 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44811541 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.44443052 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42902953 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41955285 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.41754096 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.41517988 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41399505 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40696763 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40436621 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40296357 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39576963 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39307557 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38499461 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.38327429 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37415471 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36639357 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35908031 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35138169 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34209897 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34199194 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33893086 |
| 82 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.31838280 |
| 83 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.31825403 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29482709 |
| 85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28783627 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28393440 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27887526 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26791433 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25719934 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24777221 |
| 91 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.24103842 |
| 92 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23971725 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23318104 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21644281 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.21226835 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21160367 |
| 97 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.20739272 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19881939 |
| 99 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.19671770 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18429125 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16976797 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.16497390 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16406943 |
| 104 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.15510982 |
| 105 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15263110 |
| 106 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15247766 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14593259 |
| 108 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.13676240 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13631839 |
| 110 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.13236984 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13140433 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12335485 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12230903 |
| 114 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.11760031 |
| 115 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10900879 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10841556 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10482132 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10471869 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10178275 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09322750 |
| 121 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08817525 |
| 122 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08186766 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08041718 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07721831 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07564404 |
| 126 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07386062 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07335290 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.06433093 |
| 129 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06119648 |
| 130 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04912236 |
| 131 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.04426638 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04092870 |
| 133 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03957123 |
| 134 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03727118 |
| 135 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03724473 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03528934 |
| 137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02373924 |
| 138 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01292234 |
| 139 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.01006399 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00916149 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00586823 |
| 142 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99874462 |
| 143 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99053687 |
| 144 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99011218 |
| 145 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.98879837 |
| 146 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98784097 |
| 147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97938866 |
| 148 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.97529667 |
| 149 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96803009 |
| 150 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96527076 |
| 151 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96527076 |
| 152 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95736181 |
| 153 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95706603 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.94449659 |
| 155 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94146696 |
| 156 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93975864 |
| 157 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.93958536 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93546138 |
| 159 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93531044 |
| 160 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92993809 |
| 161 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92723811 |
| 162 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92655093 |
| 163 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91109909 |
| 164 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90669499 |
| 165 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90256543 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90185122 |
| 167 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.89866628 |
| 168 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89686041 |
| 169 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88294422 |
| 170 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87014245 |
| 171 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85652947 |
| 172 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.85156403 |
| 173 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.84853926 |
| 174 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84183359 |
| 175 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84153347 |
| 176 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83821105 |
| 177 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.83546498 |
| 178 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83444866 |
| 179 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83402119 |
| 180 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.83275233 |
| 181 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83144443 |
| 182 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.82045214 |
| 183 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81380337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.95703905 |
| 2 | MP0005360_urolithiasis | 5.85898428 |
| 3 | MP0005410_abnormal_fertilization | 5.59733160 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.26360046 |
| 5 | MP0005365_abnormal_bile_salt | 3.75048449 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.73207408 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.69079989 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.54313554 |
| 9 | MP0000751_myopathy | 3.40981099 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.09992080 |
| 11 | MP0005083_abnormal_biliary_tract | 2.65519123 |
| 12 | MP0005451_abnormal_body_composition | 2.61390482 |
| 13 | MP0003252_abnormal_bile_duct | 2.56218955 |
| 14 | MP0009840_abnormal_foam_cell | 2.47352309 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.34194050 |
| 16 | MP0001764_abnormal_homeostasis | 2.29309224 |
| 17 | MP0005332_abnormal_amino_acid | 2.28870729 |
| 18 | MP0004510_myositis | 2.27681953 |
| 19 | MP0002736_abnormal_nociception_after | 2.17150423 |
| 20 | MP0003646_muscle_fatigue | 2.13680553 |
| 21 | MP0003698_abnormal_male_reproductive | 2.03002574 |
| 22 | MP0004858_abnormal_nervous_system | 2.01361496 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.99931032 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.97278841 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.95744645 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.90631468 |
| 27 | MP0003303_peritoneal_inflammation | 1.90596988 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.89077846 |
| 29 | MP0005330_cardiomyopathy | 1.88506269 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.87517172 |
| 31 | MP0003329_amyloid_beta_deposits | 1.87313117 |
| 32 | MP0000749_muscle_degeneration | 1.86157131 |
| 33 | MP0000747_muscle_weakness | 1.84920173 |
| 34 | MP0003436_decreased_susceptibility_to | 1.80646510 |
| 35 | MP0003195_calcinosis | 1.79807745 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.79127262 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.78573387 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.77652924 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.75755797 |
| 40 | MP0001929_abnormal_gametogenesis | 1.75022487 |
| 41 | MP0001849_ear_inflammation | 1.74783156 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.74530539 |
| 43 | MP0000604_amyloidosis | 1.71859064 |
| 44 | MP0000750_abnormal_muscle_regeneration | 1.71206867 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.68365047 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.67223308 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.65175147 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.63406493 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.63403403 |
| 50 | MP0005670_abnormal_white_adipose | 1.62364892 |
| 51 | MP0009697_abnormal_copulation | 1.58987069 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.57274865 |
| 53 | MP0005409_darkened_coat_color | 1.56352722 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.52021658 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.48247472 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46155719 |
| 57 | MP0004130_abnormal_muscle_cell | 1.45859781 |
| 58 | MP0004947_skin_inflammation | 1.45724625 |
| 59 | MP0003186_abnormal_redox_activity | 1.42562180 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.42081099 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.41761578 |
| 62 | MP0003718_maternal_effect | 1.39607782 |
| 63 | MP0009278_abnormal_bone_marrow | 1.38266044 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.38120000 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.36966120 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.36679263 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.36675508 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.35491146 |
| 69 | MP0000858_altered_metastatic_potential | 1.35389280 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.33774210 |
| 71 | MP0005501_abnormal_skin_physiology | 1.33560525 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.31117140 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.31036373 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.30790036 |
| 75 | MP0000609_abnormal_liver_physiology | 1.29309772 |
| 76 | MP0003011_delayed_dark_adaptation | 1.28733447 |
| 77 | MP0008438_abnormal_cutaneous_collagen | 1.28324217 |
| 78 | MP0003279_aneurysm | 1.25706089 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.25072591 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.24481029 |
| 81 | MP0002161_abnormal_fertility/fecundity | 1.24048732 |
| 82 | MP0004270_analgesia | 1.22895817 |
| 83 | MP0003091_abnormal_cell_migration | 1.21236832 |
| 84 | MP0003075_altered_response_to | 1.20231455 |
| 85 | MP0009046_muscle_twitch | 1.19353216 |
| 86 | MP0001765_abnormal_ion_homeostasis | 1.19256766 |
| 87 | MP0000733_abnormal_muscle_development | 1.19190076 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.18483293 |
| 89 | MP0005023_abnormal_wound_healing | 1.14245353 |
| 90 | MP0001873_stomach_inflammation | 1.13156795 |
| 91 | MP0003879_abnormal_hair_cell | 1.13050336 |
| 92 | MP0002653_abnormal_ependyma_morphology | 1.10756338 |
| 93 | MP0002106_abnormal_muscle_physiology | 1.09476998 |
| 94 | MP0002796_impaired_skin_barrier | 1.09180261 |
| 95 | MP0001348_abnormal_lacrimal_gland | 1.09038668 |
| 96 | MP0002249_abnormal_larynx_morphology | 1.07308355 |
| 97 | MP0005166_decreased_susceptibility_to | 1.06751112 |
| 98 | MP0006138_congestive_heart_failure | 1.06192352 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 1.05890658 |
| 100 | MP0009643_abnormal_urine_homeostasis | 1.04115186 |
| 101 | MP0001958_emphysema | 1.03856971 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 1.03473169 |
| 103 | MP0002269_muscular_atrophy | 1.03350598 |
| 104 | MP0010630_abnormal_cardiac_muscle | 1.02435724 |
| 105 | MP0000343_altered_response_to | 1.02167712 |
| 106 | MP0000685_abnormal_immune_system | 0.98680212 |
| 107 | MP0005165_increased_susceptibility_to | 0.98419238 |
| 108 | MP0002060_abnormal_skin_morphology | 0.97099566 |
| 109 | MP0005266_abnormal_metabolism | 0.96719888 |
| 110 | MP0005025_abnormal_response_to | 0.96368401 |
| 111 | MP0001529_abnormal_vocalization | 0.95953892 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.95282961 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.94654533 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.93781939 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.91611792 |
| 116 | MP0004147_increased_porphyrin_level | 0.91518441 |
| 117 | MP0001661_extended_life_span | 0.90484253 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.88376080 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.87099863 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.86958754 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.86542408 |
| 122 | MP0002163_abnormal_gland_morphology | 0.85902085 |
| 123 | MP0005408_hypopigmentation | 0.84844971 |
| 124 | MP0002733_abnormal_thermal_nociception | 0.83710352 |
| 125 | MP0005369_muscle_phenotype | 0.83667906 |
| 126 | MP0002210_abnormal_sex_determination | 0.83271441 |
| 127 | MP0003868_abnormal_feces_composition | 0.82672121 |
| 128 | MP0004272_abnormal_basement_membrane | 0.82477473 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.81988613 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.81592505 |
| 131 | MP0003828_pulmonary_edema | 0.80963160 |
| 132 | MP0009931_abnormal_skin_appearance | 0.80416203 |
| 133 | MP0005257_abnormal_intraocular_pressure | 0.79827782 |
| 134 | MP0000358_abnormal_cell_content/ | 0.79738498 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.79581080 |
| 136 | MP0005647_abnormal_sex_gland | 0.79335674 |
| 137 | MP0001145_abnormal_male_reproductive | 0.77950964 |
| 138 | MP0002419_abnormal_innate_immunity | 0.76641135 |
| 139 | MP0000653_abnormal_sex_gland | 0.76342538 |
| 140 | MP0010386_abnormal_urinary_bladder | 0.76116308 |
| 141 | MP0002971_abnormal_brown_adipose | 0.75693383 |
| 142 | MP0002272_abnormal_nervous_system | 0.75247602 |
| 143 | MP0001790_abnormal_immune_system | 0.72569583 |
| 144 | MP0005387_immune_system_phenotype | 0.72569583 |
| 145 | MP0004142_abnormal_muscle_tone | 0.72190122 |
| 146 | MP0008872_abnormal_physiological_respon | 0.72096452 |
| 147 | MP0009642_abnormal_blood_homeostasis | 0.72087357 |
| 148 | MP0001756_abnormal_urination | 0.70413881 |
| 149 | MP0002089_abnormal_postnatal_growth/wei | 0.70103501 |
| 150 | MP0002933_joint_inflammation | 0.70057708 |
| 151 | MP0001970_abnormal_pain_threshold | 0.69954464 |
| 152 | MP0005620_abnormal_muscle_contractility | 0.69874299 |
| 153 | MP0002148_abnormal_hypersensitivity_rea | 0.69688982 |
| 154 | MP0009764_decreased_sensitivity_to | 0.68378473 |
| 155 | MP0003693_abnormal_embryo_hatching | 0.67803531 |
| 156 | MP0008469_abnormal_protein_level | 0.67300081 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.67206149 |
| 158 | MP0010234_abnormal_vibrissa_follicle | 0.66128339 |
| 159 | MP0000598_abnormal_liver_morphology | 0.64075611 |
| 160 | MP0000538_abnormal_urinary_bladder | 0.63717462 |
| 161 | MP0005535_abnormal_body_temperature | 0.63192461 |
| 162 | MP0002160_abnormal_reproductive_system | 0.62662334 |
| 163 | MP0010368_abnormal_lymphatic_system | 0.61497269 |
| 164 | MP0002064_seizures | 0.61384826 |
| 165 | MP0005379_endocrine/exocrine_gland_phen | 0.59900225 |
| 166 | MP0003635_abnormal_synaptic_transmissio | 0.59408391 |
| 167 | MP0003880_abnormal_central_pattern | 0.59289412 |
| 168 | MP0005395_other_phenotype | 0.58915467 |
| 169 | MP0002078_abnormal_glucose_homeostasis | 0.58448379 |
| 170 | MP0001984_abnormal_olfaction | 0.58053128 |
| 171 | MP0008260_abnormal_autophagy | 0.55537710 |
| 172 | MP0004233_abnormal_muscle_weight | 0.55315554 |
| 173 | MP0009745_abnormal_behavioral_response | 0.52863138 |
| 174 | MP0000230_abnormal_systemic_arterial | 0.52301972 |
| 175 | MP0001905_abnormal_dopamine_level | 0.50863379 |
| 176 | MP0008874_decreased_physiological_sensi | 0.50620120 |
| 177 | MP0002132_abnormal_respiratory_system | 0.49968554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.97761708 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22477533 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.18633674 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 4.18633674 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 4.06085840 |
| 6 | Cholecystitis (HP:0001082) | 3.88622971 |
| 7 | Abnormal gallbladder physiology (HP:0012438) | 3.88622971 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.86793136 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.84361586 |
| 10 | Increased connective tissue (HP:0009025) | 3.82032874 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.79089487 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79082791 |
| 13 | Myopathic facies (HP:0002058) | 3.65307393 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.58318659 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.56023205 |
| 16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.53905250 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.52344503 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.52344503 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.48700381 |
| 20 | Distal lower limb amyotrophy (HP:0008944) | 3.36523927 |
| 21 | Infertility (HP:0000789) | 3.33350210 |
| 22 | Muscle fiber inclusion bodies (HP:0100299) | 3.33314148 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 3.31901253 |
| 24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.26860821 |
| 25 | Xanthomatosis (HP:0000991) | 3.23731094 |
| 26 | Gout (HP:0001997) | 3.22200038 |
| 27 | Nemaline bodies (HP:0003798) | 3.21677458 |
| 28 | Chronic bronchitis (HP:0004469) | 3.09070185 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.08302964 |
| 30 | Acute encephalopathy (HP:0006846) | 3.05365992 |
| 31 | Hepatocellular necrosis (HP:0001404) | 3.05355381 |
| 32 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.00217616 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.99384041 |
| 34 | Hepatic necrosis (HP:0002605) | 2.98130031 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95180797 |
| 36 | Acute necrotizing encephalopathy (HP:0006965) | 2.93659810 |
| 37 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.83986499 |
| 38 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.83986499 |
| 39 | Bulbar palsy (HP:0001283) | 2.82774791 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.82182564 |
| 41 | Rhinitis (HP:0012384) | 2.81200025 |
| 42 | Achilles tendon contracture (HP:0001771) | 2.79130329 |
| 43 | Cerebral edema (HP:0002181) | 2.78299695 |
| 44 | Hyperglycinemia (HP:0002154) | 2.76732840 |
| 45 | Poor suck (HP:0002033) | 2.75145744 |
| 46 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75067894 |
| 47 | Mitochondrial inheritance (HP:0001427) | 2.71822434 |
| 48 | Hyporeflexia of lower limbs (HP:0002600) | 2.70777937 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.67620830 |
| 50 | Lethargy (HP:0001254) | 2.66502917 |
| 51 | Malnutrition (HP:0004395) | 2.66328879 |
| 52 | Atonic seizures (HP:0010819) | 2.64680462 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.64283944 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.63102285 |
| 55 | Cholelithiasis (HP:0001081) | 2.62658030 |
| 56 | Pheochromocytoma (HP:0002666) | 2.62650847 |
| 57 | Spontaneous abortion (HP:0005268) | 2.59774501 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.54931411 |
| 59 | Thin bony cortex (HP:0002753) | 2.54688919 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.52440106 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.52080352 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.51637947 |
| 63 | Increased CSF lactate (HP:0002490) | 2.50934731 |
| 64 | Complement deficiency (HP:0004431) | 2.50791667 |
| 65 | Hyperglycinuria (HP:0003108) | 2.47900519 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.46862434 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.46689996 |
| 68 | Ketosis (HP:0001946) | 2.45911130 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.44785509 |
| 70 | Fat malabsorption (HP:0002630) | 2.44391605 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.43753910 |
| 72 | Ventricular tachycardia (HP:0004756) | 2.42067818 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.41039045 |
| 74 | Hypolipoproteinemia (HP:0010981) | 2.38627180 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 2.38485854 |
| 76 | Nasal polyposis (HP:0100582) | 2.38356680 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36742360 |
| 78 | Hyperammonemia (HP:0001987) | 2.35994622 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 2.34438384 |
| 80 | Axonal loss (HP:0003447) | 2.33921255 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.32222934 |
| 82 | Brushfield spots (HP:0001088) | 2.30120901 |
| 83 | Spinal rigidity (HP:0003306) | 2.30037436 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29305055 |
| 85 | Upper limb amyotrophy (HP:0009129) | 2.28588775 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 2.28588775 |
| 87 | Neck muscle weakness (HP:0000467) | 2.27127378 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.26514688 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.24390494 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.24390494 |
| 91 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23200611 |
| 92 | Ulnar deviation of the wrist (HP:0003049) | 2.21902378 |
| 93 | Joint hemorrhage (HP:0005261) | 2.20454183 |
| 94 | Stridor (HP:0010307) | 2.19765724 |
| 95 | Ulnar bowing (HP:0003031) | 2.19602362 |
| 96 | Easy fatigability (HP:0003388) | 2.18829617 |
| 97 | Lower limb amyotrophy (HP:0007210) | 2.18094111 |
| 98 | Polyphagia (HP:0002591) | 2.17007688 |
| 99 | Abnormality of the common coagulation pathway (HP:0010990) | 2.16904099 |
| 100 | Muscle stiffness (HP:0003552) | 2.16012531 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 2.15826985 |
| 102 | Lactic acidosis (HP:0003128) | 2.15603025 |
| 103 | Male infertility (HP:0003251) | 2.14174317 |
| 104 | CNS demyelination (HP:0007305) | 2.13575141 |
| 105 | Spastic tetraparesis (HP:0001285) | 2.13315056 |
| 106 | Abnormality of the gallbladder (HP:0005264) | 2.10394366 |
| 107 | Round ear (HP:0100830) | 2.09735753 |
| 108 | Abnormality of purine metabolism (HP:0004352) | 2.09371634 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.09300446 |
| 110 | Abnormal atrioventricular conduction (HP:0005150) | 2.08538394 |
| 111 | Sudden death (HP:0001699) | 2.07799845 |
| 112 | Cerebral hemorrhage (HP:0001342) | 2.07558688 |
| 113 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05827013 |
| 114 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05827013 |
| 115 | Myoglobinuria (HP:0002913) | 2.05820414 |
| 116 | Abnormality of nucleobase metabolism (HP:0010932) | 2.05756300 |
| 117 | Premature rupture of membranes (HP:0001788) | 2.04606383 |
| 118 | Fragile skin (HP:0001030) | 2.04364031 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 2.04226064 |
| 120 | Hypercortisolism (HP:0001578) | 2.03548677 |
| 121 | Hypercholesterolemia (HP:0003124) | 2.03038201 |
| 122 | Dysostosis multiplex (HP:0000943) | 2.02901941 |
| 123 | Abnormality of the nasal mucosa (HP:0000433) | 2.01314551 |
| 124 | Cerebral aneurysm (HP:0004944) | 1.99340597 |
| 125 | Eczematoid dermatitis (HP:0000976) | 1.98917512 |
| 126 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98525631 |
| 127 | Generalized amyotrophy (HP:0003700) | 1.98318047 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97394722 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96865146 |
| 130 | Hyperventilation (HP:0002883) | 1.96586900 |
| 131 | Oligomenorrhea (HP:0000876) | 1.95015696 |
| 132 | Conjunctival hamartoma (HP:0100780) | 1.94641570 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.93638256 |
| 134 | Delusions (HP:0000746) | 1.92918329 |
| 135 | Bundle branch block (HP:0011710) | 1.92789236 |
| 136 | Difficulty running (HP:0009046) | 1.91560152 |
| 137 | Respiratory failure (HP:0002878) | 1.91489502 |
| 138 | Emotional lability (HP:0000712) | 1.90857778 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.90668246 |
| 140 | Decreased muscle mass (HP:0003199) | 1.90609784 |
| 141 | Vascular calcification (HP:0004934) | 1.90596314 |
| 142 | Irritability (HP:0000737) | 1.89772733 |
| 143 | Abnormality of the lower motor neuron (HP:0002366) | 1.88844880 |
| 144 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88544966 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88544966 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88544966 |
| 147 | Sensorimotor neuropathy (HP:0007141) | 1.88437510 |
| 148 | Steatorrhea (HP:0002570) | 1.88165874 |
| 149 | Abnormality of complement system (HP:0005339) | 1.87703300 |
| 150 | Hyperparathyroidism (HP:0000843) | 1.87357118 |
| 151 | Autoamputation (HP:0001218) | 1.86761503 |
| 152 | Obstructive sleep apnea (HP:0002870) | 1.86532087 |
| 153 | Foot dorsiflexor weakness (HP:0009027) | 1.86309124 |
| 154 | Cervical subluxation (HP:0003308) | 1.84096553 |
| 155 | Focal motor seizures (HP:0011153) | 1.83599465 |
| 156 | Abnormal spermatogenesis (HP:0008669) | 1.82821323 |
| 157 | Testicular atrophy (HP:0000029) | 1.82042987 |
| 158 | Atrioventricular block (HP:0001678) | 1.81495668 |
| 159 | Metabolic acidosis (HP:0001942) | 1.81163305 |
| 160 | Hypertriglyceridemia (HP:0002155) | 1.79957341 |
| 161 | Hypothermia (HP:0002045) | 1.79423459 |
| 162 | Increased serum ferritin (HP:0003281) | 1.78649783 |
| 163 | Polycythemia (HP:0001901) | 1.78523803 |
| 164 | Reticulocytosis (HP:0001923) | 1.78318320 |
| 165 | Cerebral inclusion bodies (HP:0100314) | 1.78311287 |
| 166 | Right ventricular cardiomyopathy (HP:0011663) | 1.77705665 |
| 167 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76651911 |
| 168 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76651911 |
| 169 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76651911 |
| 170 | Heart block (HP:0012722) | 1.76296098 |
| 171 | Cellulitis (HP:0100658) | 1.75879656 |
| 172 | Hyperacusis (HP:0010780) | 1.73819995 |
| 173 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72371003 |
| 174 | Mucopolysacchariduria (HP:0008155) | 1.72371003 |
| 175 | Joint stiffness (HP:0001387) | 1.71378560 |
| 176 | Broad face (HP:0000283) | 1.69200967 |
| 177 | Hypertensive crisis (HP:0100735) | 1.68827818 |
| 178 | Progressive muscle weakness (HP:0003323) | 1.68740732 |
| 179 | Abnormality of the foot musculature (HP:0001436) | 1.67411218 |
| 180 | Increased muscle lipid content (HP:0009058) | 1.63714686 |
| 181 | Atrophic scars (HP:0001075) | 1.63220625 |
| 182 | Rapidly progressive (HP:0003678) | 1.63016456 |
| 183 | Back pain (HP:0003418) | 1.61960308 |
| 184 | Purpura (HP:0000979) | 1.60077445 |
| 185 | Diaphragmatic weakness (HP:0009113) | 1.58702270 |
| 186 | Aneurysm (HP:0002617) | 1.58099977 |
| 187 | Neurofibrillary tangles (HP:0002185) | 1.56882548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK3 | 5.46867816 |
| 2 | PDK4 | 5.46867816 |
| 3 | TESK1 | 4.39501652 |
| 4 | TRIB3 | 4.19766025 |
| 5 | PDK2 | 3.23411508 |
| 6 | TTN | 2.96955266 |
| 7 | SIK1 | 2.91436966 |
| 8 | IRAK3 | 2.78452345 |
| 9 | BCKDK | 2.69704502 |
| 10 | EPHA2 | 2.61838629 |
| 11 | PRPF4B | 2.60733613 |
| 12 | SMG1 | 2.56094933 |
| 13 | PRKD3 | 2.49986654 |
| 14 | ICK | 2.19381216 |
| 15 | MAP3K12 | 2.19203433 |
| 16 | ARAF | 2.10406336 |
| 17 | BRAF | 2.09488577 |
| 18 | TSSK6 | 2.06751053 |
| 19 | MAPKAPK3 | 2.00825085 |
| 20 | ERBB4 | 1.99357504 |
| 21 | MAP2K3 | 1.95370617 |
| 22 | RIPK1 | 1.95198685 |
| 23 | LATS2 | 1.86766751 |
| 24 | CDK8 | 1.73644031 |
| 25 | TAOK2 | 1.71115044 |
| 26 | MST1R | 1.67204901 |
| 27 | NEK9 | 1.66237411 |
| 28 | MAP3K3 | 1.63745019 |
| 29 | STK38L | 1.57479777 |
| 30 | CCNB1 | 1.56939218 |
| 31 | WNK4 | 1.56031682 |
| 32 | TAOK3 | 1.52231812 |
| 33 | MAP2K7 | 1.50392178 |
| 34 | PTK2B | 1.49292370 |
| 35 | EEF2K | 1.46108479 |
| 36 | BUB1 | 1.43424268 |
| 37 | TESK2 | 1.39641012 |
| 38 | EPHB1 | 1.39389463 |
| 39 | OBSCN | 1.37766121 |
| 40 | MAP2K4 | 1.35062376 |
| 41 | NEK1 | 1.32447937 |
| 42 | AKT3 | 1.28568519 |
| 43 | MAP3K4 | 1.27931536 |
| 44 | ERN1 | 1.27844709 |
| 45 | KSR2 | 1.27573206 |
| 46 | EIF2AK3 | 1.25195720 |
| 47 | STK39 | 1.23521128 |
| 48 | MAP4K1 | 1.23060120 |
| 49 | LIMK1 | 1.18519988 |
| 50 | PIM2 | 1.14120820 |
| 51 | LMTK2 | 1.12307680 |
| 52 | PRKD2 | 1.10332525 |
| 53 | ABL2 | 1.09214594 |
| 54 | PRKCG | 1.09085521 |
| 55 | PTK6 | 1.07271099 |
| 56 | PKN2 | 1.06009775 |
| 57 | PAK4 | 1.05955565 |
| 58 | PNCK | 1.02693666 |
| 59 | MINK1 | 1.02178331 |
| 60 | PHKG2 | 1.01771279 |
| 61 | PHKG1 | 1.01771279 |
| 62 | NME1 | 1.00376331 |
| 63 | NTRK1 | 0.99613020 |
| 64 | IRAK2 | 0.98953861 |
| 65 | NEK2 | 0.96887676 |
| 66 | BRSK2 | 0.95192132 |
| 67 | IRAK4 | 0.94534949 |
| 68 | FGFR4 | 0.93673604 |
| 69 | MARK2 | 0.93638095 |
| 70 | MAPK12 | 0.92437383 |
| 71 | EIF2AK1 | 0.90109652 |
| 72 | RPS6KA2 | 0.89192485 |
| 73 | PTK2 | 0.88438296 |
| 74 | MAP3K10 | 0.85688398 |
| 75 | ZAP70 | 0.85685751 |
| 76 | MAP3K9 | 0.84018114 |
| 77 | CASK | 0.83333304 |
| 78 | STK38 | 0.82928074 |
| 79 | ACVR1B | 0.82391766 |
| 80 | SCYL2 | 0.81636648 |
| 81 | MAP2K2 | 0.81217526 |
| 82 | AURKA | 0.80158237 |
| 83 | MAP2K1 | 0.79907857 |
| 84 | MAP3K14 | 0.79263592 |
| 85 | NTRK3 | 0.79012773 |
| 86 | GRK5 | 0.78986620 |
| 87 | NME2 | 0.78296131 |
| 88 | RPS6KL1 | 0.77801576 |
| 89 | RPS6KC1 | 0.77801576 |
| 90 | DMPK | 0.77391657 |
| 91 | CDC42BPA | 0.77357523 |
| 92 | SIK3 | 0.76984562 |
| 93 | BMX | 0.76006223 |
| 94 | MAP3K11 | 0.74735084 |
| 95 | BLK | 0.74451296 |
| 96 | TAOK1 | 0.74359737 |
| 97 | MAPKAPK5 | 0.74327132 |
| 98 | DYRK2 | 0.73630881 |
| 99 | BRSK1 | 0.72606680 |
| 100 | MST4 | 0.72099155 |
| 101 | MAPK11 | 0.70583258 |
| 102 | PINK1 | 0.69137499 |
| 103 | MTOR | 0.68846790 |
| 104 | MUSK | 0.68514945 |
| 105 | DDR2 | 0.66367659 |
| 106 | STK16 | 0.66198549 |
| 107 | GRK6 | 0.66059927 |
| 108 | MAP3K6 | 0.65978570 |
| 109 | SIK2 | 0.65122878 |
| 110 | PDGFRA | 0.64144810 |
| 111 | MAP3K8 | 0.64011190 |
| 112 | DYRK1B | 0.63715641 |
| 113 | MOS | 0.62890486 |
| 114 | TBK1 | 0.61834401 |
| 115 | PRKG2 | 0.61251739 |
| 116 | DAPK1 | 0.60888059 |
| 117 | RIPK4 | 0.59313160 |
| 118 | CSK | 0.59005618 |
| 119 | MET | 0.57063505 |
| 120 | MAPK13 | 0.55964587 |
| 121 | LRRK2 | 0.55214423 |
| 122 | RPS6KA6 | 0.54849756 |
| 123 | KDR | 0.54551394 |
| 124 | MYLK | 0.54369271 |
| 125 | TYK2 | 0.53160635 |
| 126 | MAP3K1 | 0.52844629 |
| 127 | ILK | 0.48509697 |
| 128 | MAPK15 | 0.48404609 |
| 129 | PLK4 | 0.47917429 |
| 130 | TGFBR2 | 0.47410338 |
| 131 | MAP3K7 | 0.47209569 |
| 132 | HIPK2 | 0.46745389 |
| 133 | PDK1 | 0.46634034 |
| 134 | CDK14 | 0.46541943 |
| 135 | TNK2 | 0.45939708 |
| 136 | MAP2K6 | 0.45889869 |
| 137 | MAPK4 | 0.45229787 |
| 138 | PAK1 | 0.44579685 |
| 139 | INSRR | 0.44528276 |
| 140 | CDK12 | 0.44368907 |
| 141 | PRKD1 | 0.43754149 |
| 142 | RAF1 | 0.41690460 |
| 143 | PDPK1 | 0.41188115 |
| 144 | MAP3K13 | 0.40626802 |
| 145 | AKT2 | 0.40421184 |
| 146 | MATK | 0.40389287 |
| 147 | MARK3 | 0.40156000 |
| 148 | MAPK7 | 0.39680862 |
| 149 | CAMKK2 | 0.39298173 |
| 150 | PRKCZ | 0.38235551 |
| 151 | MAPKAPK2 | 0.37330813 |
| 152 | PLK1 | 0.37025796 |
| 153 | CDK18 | 0.35645788 |
| 154 | CAMK2G | 0.34153712 |
| 155 | CDK15 | 0.33135589 |
| 156 | PRKCI | 0.31568380 |
| 157 | PRKAA1 | 0.31456072 |
| 158 | EPHB2 | 0.29831471 |
| 159 | PLK2 | 0.29120413 |
| 160 | WNK3 | 0.28554246 |
| 161 | SGK223 | 0.26956414 |
| 162 | SGK494 | 0.26956414 |
| 163 | CAMKK1 | 0.26904862 |
| 164 | ADRBK1 | 0.26562888 |
| 165 | CAMK2A | 0.26249681 |
| 166 | SGK2 | 0.25830982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.98889839 |
| 2 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.96629409 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91054326 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.89559548 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.58894117 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56341350 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26922382 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.22767644 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22702957 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16985656 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13074814 |
| 12 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.08598323 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00306933 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.99827893 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94397374 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.91105269 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89363293 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.86708454 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81805262 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81722172 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80642014 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.79616226 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78918281 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.78666300 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71186728 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.67357789 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64743352 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64679192 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63562635 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62484343 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61123171 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59954321 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59497493 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57373195 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55659075 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.55175289 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.54564713 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52732887 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46148494 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46090784 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45211611 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45070749 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44847426 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44571110 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.43720635 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.40779892 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.39966227 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37143813 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.35634923 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34106023 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30423161 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30334829 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29064673 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26433740 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25638872 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24103511 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23184616 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20789570 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.19442047 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16813116 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 1.15260651 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 1.13873691 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13357868 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13165861 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12786728 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10651141 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09269914 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07782247 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07225806 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05976644 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05946291 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05765244 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04963639 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04453015 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04091539 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03652020 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99415532 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99123692 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97691781 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97580208 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97236212 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96986529 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96479489 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95477782 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92351896 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.91621009 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91390156 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.91117384 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.90641598 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89549381 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.87702676 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.85802093 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84617732 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83546697 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.81748860 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79387521 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79095192 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78962796 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78656016 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78415999 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77604943 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75715383 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74979474 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74095378 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.72951003 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72852997 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72536949 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71167216 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70527379 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69579685 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.69167275 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68848214 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.68424787 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68167757 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68097640 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67146218 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.67064522 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65087603 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64928479 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64904015 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64546519 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64119673 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63920854 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63624824 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63382955 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63105295 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.63043327 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62606943 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62064184 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61073507 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.60469155 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59655516 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57924578 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55770525 |
| 135 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53748419 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53632599 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53269425 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.53143528 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52504709 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52358197 |
| 141 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51328560 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50705257 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.50225409 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49616853 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.47704025 |
| 146 | Hepatitis B_Homo sapiens_hsa05161 | 0.47504608 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47361702 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46231961 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46150184 |
| 150 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45894346 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45199915 |
| 152 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44195430 |
| 153 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41296765 |
| 154 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40181462 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39324544 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38067022 |
| 157 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34842139 |
| 158 | Phagosome_Homo sapiens_hsa04145 | 0.33923219 |
| 159 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31740439 |
| 160 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30230209 |
| 161 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30071266 |
| 162 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26249132 |
| 163 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25181894 |
| 164 | Purine metabolism_Homo sapiens_hsa00230 | 0.22741804 |
| 165 | RNA polymerase_Homo sapiens_hsa03020 | 0.21475653 |
| 166 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19865865 |
| 167 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17976491 |

